ProKidney Corp.
PROK
Last
$1.74
Day
+4.8%
1y
-49.7%
5y
-80.8%
52w
-52.3%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0930d
EMA 21
1.68
EMA 50
1.70
EMA 200
1.85
20d high
-16.2%
5y high
-88.3%
5y range
9th
Positions held
Your positionsPROK isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-21
Hold
avoid
Signal
Strong Sell
Target
$1.85
Stop
$1.50
Stop distance
13.8%
Target vs last
+6.3%
Fundamentals
| Market cap | $662.64M | Enterprise value | $1.28B | Trailing P/E | — | Forward P/E | -2.83 |
| PEG | — | Price / book | -0.39 | Beta | 1.80 | Dividend yield | 0.00% |
| Revenue growth | -32.1% | Earnings growth | — | Gross margin | 100.0% | Operating margin | -322.5% |
| Profit margin | 0.0% | ROE | -59.0% | ROA | -35.7% | Debt / equity | 0.02 |
| Current ratio | 8.36 | Free cash flow | -$83.84M | Analyst recommendation | none | Mean target | $6.25 |
| 52w high | $3.48 | 52w low | $1.30 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.1M | $0.2M | $0.2M | $0.2M | $0.2M | — |
| Op margin | -32248.7% | -19881.9% | -20164.9% | -17759.9% | -17967.9% | — |
| Net income | -$28.4M | -$20.0M | -$19.2M | -$16.5M | -$16.6M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$48.4M | -$44.9M | -$45.4M | -$38.5M | -$39.7M | — |
- Revenue -34% vs prior quarter ($0.1M vs $0.2M).
- Operating margin compressed to -32248.7%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.9M | $0.1M | $0.0M | $0.0M |
| Op margin | -18477.8% | -241678.9% | — | — |
| Net income | -$69.0M | -$61.2M | -$35.5M | -$108M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$165M | -$184M | -$152M | -$153M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-11 · ProKidney (PROK) Nears A Pivotal Kidney Therapy Verdict
2026-08-20 · Prokidney Insider Sold Shares Worth $1,067,773, According to a Recent SEC Filing
2026-08-10 · ProKidney Corp. (PROK) Reports Q2 Loss, Misses Revenue Estimates
2026-08-10 · ProKidney Reports Second Quarter 2026 Financial Results and Business Highlights
Price (daily)
Full chart · RSI · MACD · patternsPROK · daily-9.3% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin